Bostrom MP, Asnis P, Toledano T, Hill EL, Avnur Z, Vickery B
This multicenter, randomized, double-blind, placebo-controlled trial included patients aged at least 50 years with T2D who had either a previous CV event or risk factors
This medication may be suitable for those requiring significant weight loss or those who haven't been satisfied with single-agonist treatments
Skov J, Pedersen M, Holst JJ, Madsen B, Goetze JP, Rittig S, Jonassen T, Frokiaer J, Dejgaard A, Christiansen JS
Reported side effects from limited studies include injection site reactions, temporary redness, and localized inflammation
Your weight loss journey doesnt have to be a mystery